Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 9:39 PM
Ignite Modification Date:
2025-12-25 @ 7:21 PM
NCT ID:
NCT03250832
Group ID:
EG007
Title:
Part 2A - TSR-033 (720 mg) + Dostarlimab (1000 mg)
Description:
Anti-programmed cell death-1 receptor (PD-1) naive participants with advanced or metastatic microsatellite stable colorectal cancer (MSS-CRC) that progressed following 2 or 3 prior lines of therapy received IV infusion of 720 mg TSR-033 once Q2W in combination with 1000 mg dostarlimab once every 6 weeks (Q6W).
Deaths Number Affected:
18
Deaths Number At Risk:
None
Serious Number Affected:
8
Serious Number At Risk:
34
Other Number Affected:
31
Other Number At Risk:
34
Study:
NCT03250832
Results Section:
NCT03250832
Adverse Events Module:
NCT03250832